Tolerance and Pharmacokinetic/Pharmacokinetic Study of IBI362 15mg in Patients With Moderate to Severe Obesity
Clinical trial NCT07000955 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT07000955
- Sponsor
- Innovent Biologics (Suzhou) Co. Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-06-17
- Primary completion
- 2026-09-30
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.